RO73527A - Procede de preparation des derives de 15 alpha,16 alpha-methylen-4-oestren-17-beta-oles - Google Patents

Procede de preparation des derives de 15 alpha,16 alpha-methylen-4-oestren-17-beta-oles

Info

Publication number
RO73527A
RO73527A RO7373805A RO7380573A RO73527A RO 73527 A RO73527 A RO 73527A RO 7373805 A RO7373805 A RO 7373805A RO 7380573 A RO7380573 A RO 7380573A RO 73527 A RO73527 A RO 73527A
Authority
RO
Romania
Prior art keywords
alpha
oestren
methylen
beta
preparation
Prior art date
Application number
RO7373805A
Other languages
English (en)
Romanian (ro)
Inventor
Rudolf Wiechert
Herman Steinbeck
Walter Elgeer
Original Assignee
Schering Ag,Bw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag,Bw filed Critical Schering Ag,Bw
Publication of RO73527A publication Critical patent/RO73527A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RO7373805A 1972-02-11 1973-02-10 Procede de preparation des derives de 15 alpha,16 alpha-methylen-4-oestren-17-beta-oles RO73527A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (de) 1972-02-11 1972-02-11 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
RO73527A true RO73527A (fr) 1982-02-01

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
RO7373805A RO73527A (fr) 1972-02-11 1973-02-10 Procede de preparation des derives de 15 alpha,16 alpha-methylen-4-oestren-17-beta-oles

Country Status (29)

Country Link
JP (1) JPS5829317B2 (fr)
KR (1) KR780000156B1 (fr)
AT (1) AT327413B (fr)
AU (1) AU467306B2 (fr)
BE (1) BE795241A (fr)
CA (1) CA997753A (fr)
CH (2) CH593995A5 (fr)
CS (1) CS193019B2 (fr)
DD (1) DD102379A5 (fr)
DE (1) DE2207421C3 (fr)
DK (1) DK131037B (fr)
EG (1) EG10914A (fr)
ES (1) ES410933A1 (fr)
FI (1) FI52225C (fr)
FR (1) FR2181719B1 (fr)
GB (1) GB1425636A (fr)
GR (1) GR63160B (fr)
HU (1) HU165253B (fr)
IE (1) IE37266B1 (fr)
IL (1) IL41506A (fr)
NL (1) NL177217C (fr)
NO (2) NO140304C (fr)
PH (1) PH9370A (fr)
PL (1) PL81084B1 (fr)
RO (1) RO73527A (fr)
SE (3) SE403781B (fr)
SU (1) SU513628A3 (fr)
YU (1) YU35035B (fr)
ZA (1) ZA73944B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (de) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten

Also Published As

Publication number Publication date
PL81084B1 (fr) 1975-08-30
FI52225C (fi) 1977-07-11
SE7713896L (sv) 1977-12-07
SE426834B (sv) 1983-02-14
IE37266L (en) 1973-08-11
JPS4886856A (fr) 1973-11-15
KR780000156B1 (en) 1978-05-02
HU165253B (fr) 1974-07-27
CS193019B2 (en) 1979-09-17
CH590883A5 (fr) 1977-08-31
IE37266B1 (en) 1977-06-08
EG10914A (en) 1976-09-30
NO143065C (no) 1980-12-10
DK131037B (da) 1975-05-20
AU467306B2 (en) 1975-11-27
YU35035B (en) 1980-06-30
GB1425636A (en) 1976-02-18
SE409329B (sv) 1979-08-13
IL41506A (en) 1976-07-30
SU513628A3 (ru) 1976-05-05
IL41506A0 (en) 1973-04-30
ES410933A1 (es) 1976-03-01
DK131037C (fr) 1975-10-20
NL7301974A (fr) 1973-08-14
NO140304B (no) 1979-04-30
FI52225B (fr) 1977-03-31
AU5207673A (en) 1974-08-15
FR2181719A1 (fr) 1973-12-07
NL177217B (nl) 1985-03-18
CH593995A5 (fr) 1977-12-30
GR63160B (en) 1979-09-25
AT327413B (de) 1976-01-26
PH9370A (en) 1975-10-22
NO140304C (no) 1979-08-08
SE403781B (sv) 1978-09-04
DD102379A5 (fr) 1973-12-12
ZA73944B (en) 1973-11-28
DE2207421C3 (de) 1981-05-07
FR2181719B1 (fr) 1975-11-21
NO143065B (no) 1980-09-01
YU24373A (en) 1979-12-31
NL177217C (nl) 1985-08-16
CA997753A (en) 1976-09-28
DE2207421A1 (de) 1973-08-16
ATA112473A (de) 1975-04-15
DE2207421B2 (de) 1980-07-24
NO782754L (no) 1973-08-14
BE795241A (fr) 1973-08-09
JPS5829317B2 (ja) 1983-06-22
SE7514513L (sv) 1975-12-22

Similar Documents

Publication Publication Date Title
RO62879A (fr) Procede pour la preparation des derives du 1,2,3-thiadiazole
BE808733A (fr) Procede de preparation de cyclohexane-diones-1,3
RO62914A (fr) Procede pour la preparation des derives des 2-alkylaminodihydropyridines
RO66268A (fr) Procede pour la preparation des derives du 1-phenoxy-3-aminopropan-2-ole
BE774202A (fr) Procede de preparation de la n,n,n',n'-tetraacetyl-ethylene- diamine
BE800599A (fr) Procede de preparation d'amides dimethyl-2,5 furanne- carboxyliques-3
RO63409A (fr) Procede pour la preparation des derives de s-triazolo-(4,3-a)-quinolines
CH553207A (fr) Procede pour la preparation de derives azotes.
BE805491A (fr) Procede de preparation de 4-hydroxy-cyclopentane-1,3-diones substituees en position 2
RO62662A (fr) Procede pour la preparation des derives du oxindol
CH550195A (fr) Procede de preparation de derives d'isoxazolopyridinecetones.
RO71937A (fr) Procede pour la preparation des derives de benzodioxole
RO63006A (fr) Procede pour la preparation des derives du 2-hydrazinobenzthiazole
BE802021A (fr) Procede de preparation de nouveaux derives du 1,1a
BE776050A (fr) Procede de preparation de derives d'ureidophenoxy-alcanolamines.
RO73527A (fr) Procede de preparation des derives de 15 alpha,16 alpha-methylen-4-oestren-17-beta-oles
BE806255A (fr) Procede de preparation de derives de la morphanthridinone
RO76175A (fr) Procede pour -a preparation des derives de benzihydrol-alpha-substitus
CH548985A (fr) Procede de preparation des derives du benzamide.
BE807995A (fr) Procede de preparation de 1-nitro-anthraquinone pratiquement exempte de 1,5-dinitro-anthraquinone
CH549577A (fr) Procede de preparation de nouveaux derives de la malonyluree.
CH557834A (fr) Procede de preparation de derives de la thiazolidine.
RO66744A (fr) Procede pour la preparation des derives de isoxazolidine
CH550795A (fr) Procede de preparation de derives d'imidocarbonyle.
BE808552A (fr) Procede de preparation de 2,3,4,5,6,7- hexahydrocyclopenta-(e)-1,3-oxazine-2-4-diones